SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-17-004887
Filing Date
2017-08-09
Accepted
2017-08-09 15:23:59
Documents
72
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_080917p.htm 10-Q 885119
2 EXHIBIT 31.1 exh_311.htm EX-31.1 6503
3 EXHIBIT 31.2 exh_312.htm EX-31.2 6529
4 EXHIBIT 32.1 exh_321.htm EX-32.1 3503
  Complete submission text file 0001171843-17-004887.txt   5613522

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE args-20170630.xml EX-101.INS 912950
6 XBRL SCHEMA FILE args-20170630.xsd EX-101.SCH 73590
7 XBRL CALCULATION FILE args-20170630_cal.xml EX-101.CAL 30078
8 XBRL DEFINITION FILE args-20170630_def.xml EX-101.DEF 548820
9 XBRL LABEL FILE args-20170630_lab.xml EX-101.LAB 418156
10 XBRL PRESENTATION FILE args-20170630_pre.xml EX-101.PRE 559898
Mailing Address 4233 TECHNOLOGY DR DURHAM NC 27704
Business Address 4233 TECHNOLOGY DR DURHAM NC 27704 9192876300
ARGOS THERAPEUTICS INC (Filer) CIK: 0001105533 (see all company filings)

IRS No.: 562110007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35443 | Film No.: 171017662
SIC: 2834 Pharmaceutical Preparations